Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

CompletedOBSERVATIONAL

Enrollment

2,609

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

August 31, 2011

Study Completion Date

November 30, 2012

Conditions

Ophthalmology, Macular Degeneration

Interventions

DRUG

Ranibizumab

Patients with wet AMD treated with ranibizumab as prescribed by physician

Trial Locations (10)

Many Locations